y and proteasome inhibitors [J] . Med Res Rev, 2001,21(4):245 - 273 . [7] O' Leary K A, Mendrysa S M, aro A, et al. Mdm2 regu-lates p53 independently of p19(ARF) in homeostatic tissues[J] . Mol Cell Biol, 2004,24(1):186 - 191 . [8] Brooks C L, Gu W, Dynamics in the p53 - Mdm2 ubiquitination pathway[J] . Cell Cycle, 2004,3(7):895 - 899 . [9]Alkalay I, Yaron A, Hatzubai A, et al. Stimulation - dependent I kappa B alpha phosphorylation marks the NF - kappa B in-hibitor for degradation via the ubiquitin - proteasome pathway[J] . Proc Natl Acad Sci USA, 1995,92(23):10599 - 10603 . [10] Margottin F, Bour S P, Durand H, et al.A novel human WD protein, h- beta TrCp, that interacts with HIV -1 Vpu connects CD4 to the ER degradation pathway through anF- box motif[J] . Mol Cell, 1998,1(4):565 - 574 .